(Q56876471)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12398895%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

title

Fas ligand breaks tolerance to self-antigens and induces tumor immunity mediated by antibodies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12398895%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12398895%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

Awen Gallimore

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12398895%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

Emma Jones

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12398895%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

Birgit Sawitzki

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12398895%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

Vincenzo Cerundolo

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12398895%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

Gavin R Screaton

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12398895%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

publication date

1 October 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12398895%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12398895%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

volume

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12398895%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

page(s)

315-322

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12398895%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12398895%20AND%20SRC:MED&resulttype=core&format=json

Transgenic expression of CD95 ligand on islet beta cells induces a granulocytic infiltration but does not confer immune privilege upon islet allografts.

14 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900151-4

7 January 2021

A role for CD95 ligand in preventing graft rejection

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900151-4

7 January 2021

Regulation of the proinflammatory effects of Fas ligand (CD95L).

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900151-4

7 January 2021

Newly discovered role for Fas ligand in the cell-cycle arrest of CD4+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900151-4

7 January 2021

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900151-4

7 January 2021

Is cancer dangerous to the immune system?

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900151-4

7 January 2021

The role of Fas ligand in immune privilege

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900151-4

7 January 2021

Fas Ligand-Induced Apoptosis as a Mechanism of Immune Privilege

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900151-4

7 January 2021

Interaction of peptides derived from the Fas ligand with the Fyn-SH3 domain

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900151-4

7 January 2021

Implicating a role for immune recognition of self in tumor rejection: passive immunization against the brown locus protein

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900151-4

7 January 2021

Opposing effects of transmembrane and soluble Fas ligand expression on inflammation and tumor cell survival

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900151-4

7 January 2021

Fas ligand engagement of resident peritoneal macrophages in vivo induces apoptosis and the production of neutrophil chemotactic factors

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900151-4

7 January 2021

Monoclonal antibody therapies-a 'constant' threat to cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900151-4

7 January 2021

Regulation of activation-induced cell death of mature T-lymphocyte populations

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900151-4

7 January 2021

Induction of tumor-specific T cell memory by NK cell–mediated tumor rejection

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900151-4

7 January 2021

Caspase activation is required for T cell proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900151-4

7 January 2021

CD95's deadly mission in the immune system

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900151-4

7 January 2021

A renaissance for the tumor immunosurveillance hypothesis.

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900151-4

7 January 2021

Cutaneous injection of human subjects with macrophage inflammatory protein-1 alpha induces significant recruitment of neutrophils and monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900151-4

7 January 2021

Expression of the chemokine N51/KC in the thymus and epidermis of transgenic mice results in marked infiltration of a single class of inflammatory cells

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900151-4

7 January 2021

The CD95 system and the death of a lymphocyte

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900151-4

7 January 2021

Caspase 1-independent IL-1β release and inflammation induced by the apoptosis inducer Fas ligand

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900151-4

7 January 2021

Immune response to a differentiation antigen induced by altered antigen: a study of tumor rejection and autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900151-4

7 January 2021

Immune privilege or inflammation? Insights into the Fas ligand enigma

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900151-4

7 January 2021

Roles of tumour localization, second signals and cross priming in cytotoxic T-cell induction

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900151-4

7 January 2021

gp100/pmel 17 is a murine tumor rejection antigen: induction of "self"-reactive, tumoricidal T cells using high-affinity, altered peptide ligand

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900151-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900151-4

1 reference

7 January 2021

CD4 monoclonal antibody pairs for immunosuppression and tolerance induction

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900151-4

7 January 2021

Fas engagement induces the maturation of dendritic cells (DCs), the release of interleukin (IL)-1beta, and the production of interferon gamma in the absence of IL-12 during DC-T cell cognate interaction: a new role for Fas ligand in inflammatory res

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900151-4

7 January 2021

Fas ligand expression by astrocytoma in vivo: maintaining immune privilege in the brain?

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900151-4

7 January 2021

Characterization of Fas (Apo-1, CD95)-Fas ligand interaction

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900151-4

7 January 2021

Antitumor effect of locally produced CD95 ligand

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900151-4

7 January 2021

Immunoglobulin G monoclonal antibodies to Cryptococcus neoformans protect mice deficient in complement component C3

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900151-4

7 January 2021

Fas/Apo-1 (CD95)-mediated apoptosis of neutrophils with Fas ligand (CD95L)-expressing tumors is crucial for induction of inflammation by neutrophilic polymorphonuclear leukocytes associated with antitumor immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900151-4

7 January 2021

A fresh look at tumor immunosurveillance and immunotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900151-4

7 January 2021

Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900151-4

7 January 2021

Maximal proliferation of cytotoxic T lymphocytes requires reverse signaling through Fas ligand

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900151-4

7 January 2021

Protein LA, a novel hybrid protein with unique single-chain Fv antibody- and Fab-binding properties

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900151-4

7 January 2021

FcR gamma chain deletion results in pleiotrophic effector cell defects

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900151-4

7 January 2021

Tumor expression of Fas ligand (CD95L) and the consequences

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900151-4

7 January 2021

10.1016/S1535-6108(02)00151-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12398895%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

1 reference